Patents by Inventor Jolieke Gerdy van Oosterwijk

Jolieke Gerdy van Oosterwijk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11850280
    Abstract: The inventive subject matter includes a viral-vectored composition made of a bacterial expression vehicle expressing one or more recombinant viral protein antigens and its method of use. In particular, this invention relates to a vaccine for oral administration. Preferably, the bacterial expression vehicle is Bacillus subtilis.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: December 26, 2023
    Assignee: US Biologic, Inc
    Inventors: Jolieke Gerdy van Oosterwijk, Andrew Raymond Peters, Douglas Steven Zatechka, Jr., Luciana Meirelles Richer, Christopher Anthony Przybyszewski
  • Patent number: 11814628
    Abstract: The inventive subject matter includes an antimicrobial peptide vectored composition made of a bacterial protein expression vehicle expressing one or more recombinant antimicrobial peptide effector molecules. More specifically these novel recombinant antimicrobial peptide effector molecules exhibit preferential anti-microbial activity. The utility of the current inventive subject matter has demonstrated a reduced viability of Eimeira acervulina sporozoites in vitro using a sporozoite killing assay. More specifically, the antimicrobial peptide vectored composition is a bacterial protein expression vehicle expressing one or more recombinant antimicrobial peptide effector molecules, wherein the one or more recombinant antimicrobial peptide effector molecules are engineered from a NK-lysin gene and the one or more recombinant antimicrobial peptide effector molecules are engineered to express functionally active NK-2.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: November 14, 2023
    Assignee: US Biologic, Inc
    Inventors: Jolieke Gerdy Van Oosterwijk, Luciana Meirelles Richer, Douglas Steven Zatechka, Woohyun Kim, Hyun Soon Lillehoj, Cyril Gray, Christopher Anthony Przybyszewski
  • Patent number: 11771746
    Abstract: Through the use of a universal anti-tick antigens, multiple tick-borne diseases that occur over a significant area can be targeted for eradication. The novel reservoir targeted anti-tick treatment is designed to reduce tick numbers and thereby blocking transmission of tick-borne diseases.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: October 3, 2023
    Assignee: US Biologic, Inc
    Inventors: Jolieke Gerdy van Oosterwijk, Douglas Steven Zatechka, Jr., Luciana Meirelles Richer
  • Publication number: 20230272407
    Abstract: The inventive subject matter includes an antimicrobial peptide vectored composition made of a bacterial protein expression vehicle expressing one or more recombinant antimicrobial peptide effector molecules. More specifically these novel recombinant antimicrobial peptide effector molecules exhibit preferential anti¬microbial activity. The utility of the current inventive subject matter has demonstrated a reduced viability of Eimeira acervulina sporozoites in vitro using a sporozoite killing assay. More specifically, the antimicrobial peptide vectored composition is a bacterial protein expression vehicle expressing one or more recombinant antimicrobial peptide effector molecules, wherein the one or more recombinant antimicrobial peptide effector molecules are engineered from a NK-lysin gene and the one or more recombinant antimicrobial peptide effector molecules are engineered to express functionally active NK-2.
    Type: Application
    Filed: June 14, 2021
    Publication date: August 31, 2023
    Applicants: US Biologic, Inc., The United States of America as represented by the Secretary of Agriculture
    Inventors: Jolieke Gerdy van Oosterwijk, Luciana Meirelles Richer, Douglas Steven Zatechka, Woohyun Kim, Hyun Soon Lillehoj, Cyril Gray, Christopher Anthony Przybyszewski
  • Publication number: 20230127041
    Abstract: Through the use of a universal anti-tick antigens, multiple tick-borne diseases that occur over a significant area can be targeted for eradication. The novel reservoir targeted anti-tick treatment is designed to reduce tick numbers and thereby blocking transmission of tick-borne diseases.
    Type: Application
    Filed: January 10, 2022
    Publication date: April 27, 2023
    Applicant: US BIOLOGIC, INC
    Inventors: Jolieke Gerdy van Oosterwijk, Douglas Steven Zatechka, Luciana Meirelles Richer
  • Patent number: D1002847
    Type: Grant
    Filed: August 28, 2021
    Date of Patent: October 24, 2023
    Assignee: Orange LLC
    Inventors: Jolieke Gerdy van Oosterwijk, Ian Nicholas Johnson, Benjamin Silberberg, Tifahri Yusuf, William Chase Guyton